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<ABSTRACT>
Adult Asthma Exacerbation and Respiratory Syncytial Virus 
Specific IgE Detection in Sputa
Yong Won Lee
Department of Medicine
The Graduate School, Yonsei University 
(Directed by Professor Jung-Won Park)
 Background: Acute exacerbation in asthmatics has been believed to be 
closely associated with respiratory viral infections. Considering the 
possibility of viral antigen sensitization, several studies had tried to detect 
respiratory syncytial virus (RSV) virus specific IgE from mice models and 
asthmatics. However, such approaches have not yet been fully established. 
 Materials & Methods: We investigated the respiratory viral detection rate, 
species, seasonal variation, and sequential dynamics with total 132 induced 
sputa samples, collected for two years, from lower airway of Korean adult 
asthmatics (n=60) and controls (n=10) with acutely exacerbated respiratory 
symptoms. Multiplex reverse trascriptase-polychain reaction (mPCR) for 12 
respiratory viral species (adenovirus, rhino A virus, coronavirus OC43 and 
229E/NL63, metapneumovirus, influenza A and B virus, parainfluenza 
viruses 1, 2, 3, and respiratory syncytial virus (RSV) A and B) were 
performed with those specimens. Then, we selected total 50 sputa samples 
and, with those specimens, detected specific IgE (in sputa supernatant) to 
crude RSV whole antigens and its recombinant attachment G protein core  
fragment (Gcf) by ImmunoCAP system (CAP), and measured Interferon-γ, 
IL-5, and IL13 by ELISA. 
 Results: Among 132 induced sputum samples, total 15 respiratory viral 
detections in mPCR were observed in asthma patients and COPD controls 
(n= 13, and 2, respectively). RSV was the most frequently detected 
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species among these (53%, 8/15). One multiple and two sequential 
detections were observed in three asthmatics. Among asthmatics, CAP 
specific IgE to Gcf (Gcf-sIgE) and IL-5 in sputa supernatant were higher 
in the subjects with RSV detection by mPCR (p<0.05, respectively). 
RSV-sIgE, Interferon-γ and IL-13 were detected in several subjects but 
failed to show statistical differences between the groups. In ROC analyses 
with the CAP measured asthmatics, the best coordinate cutoff of Gcf-sIgE, 
predicting RSV detection by mPCR, was 0.285 kU/L (AUC 0.73, 95% CI 
0.47-0.82; SE 81.3%, SP 65.4%, PPV 59.1%, NPV 85.0%). 
 Conclusions: In this study, RSV was the most frequently detected viral 
species among the sputa from the exacerbated adult asthmatics. We 
applied the conventional CAP immunoassay to detecting the specific IgE 
antibodies to crude RSV whole antigens and its Gcf, using the sputum 
samples. Gcf-sIgE and IL-5 elevation in the sputa from the adult 
asthmatics with ever detections of RSV by mPCR, suggests that RSV 
protein sensitization and Th2 pathway may have roles on RSV associated  
asthma exacerbations in adults. 

Key Words : adult asthma, exacerbation, sputum, respiratory syncytial 
virus (RSV), immunoglobulin E (IgE)
- 3 -
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Yong Won Lee
Department of Medicine
The Graduate School, Yonsei University 
(Directed by Professor Jung-Won Park)
I. INTRODUCTION
 Acute exacerbation in asthmatics has been believed to be closely 
associated with respiratory viral infections for a long time.1-4 For 
example, the relationship between asthma exacerbations and the common 
cold, combined with seasonal variation, has been recognized for nearly 
hundreds of years.5 Such association has been well studied mainly in 
children, however, adult asthmatics, especially elderly, are not free from 
this, and a large amount of clinical and epidemiologic studies have also 
revealed such association.1,5-8  
 It is well known that respiratory syncytial virus (RSV) infection during 
early childhood can precede the subsequent airway hyperresponsiveness 
and the development of chronic asthma in later life.3-7,9 Respiratory 
viruses including RSV and rhinovirus seem to be closely linked to 
exacerbations in the physiologic and immunologic intensity of an 
asthmatic response and can trigger 80% and 50% of childhood and adult 
asthma exacerbation, respectively.3,6,7,9,10 Wos, et al. reported that human 
rhinovirus (HRV) was detected in the lower airway tissue of patients 
with asthma significantly more often than in non-asthmatic subjects, and 
its presence was associated with clinical features of more severe disease.11 
 Several studies reported that viral infection induced interferon prolonged 
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symptoms and increased severity of asthmatics.10,12-15 Johnston, et al. 
suggested the role of innate immunity in pathogenesis of virus-induced 
asthma exacerbation.16 They suggested that deficiency of certain interferon 
types in asthmatics might explain virus-induced asthma exacerbations.15 
Maybe due to such host factors, a number of respiratory viruses have 
been found to have latency or persistence.17 Especially, RSV latency and 
persistence were reported in both mouse models and patients with chronic 
obstructive pulmonary disease.18,19 Kim, et al. suggested that transition 
from respiratory viral infection into chronic lung disease requires 
persistent activation of a novel NKT cell-macrophage innate immune axis 
with mouse model infected by Sendai virus similar to RSV.20 Although 
there are several studies contradicting above results,21,22 dynamics of 
human respiratory virus and related immune cells in human airways 
during episodes of upper respiratory infection has been continuously 
evaluated.22,23 
 However, conventional respiratory viral detection methods like viral 
culture showed only limited clinical values because of time-cost 
consuming procedure and low sensitivity to fastidious viruses.8,24 For the 
last one decade, polymerase chain reaction (PCR)-based methods have 
been considered as a candidate for the optimum method in virus 
detection, and several studies using PCR technique have reported that 
respiratory viruses are in charge of a much higher proportion of asthma 
exacerbations than were previously suspected.2 For the diagnosis of acute 
respiratory tract infections, reverse transcriptase PCR (RT-PCR) has the 
advantage of detecting fastidious viral organisms such as rhinoviruses in 
comparison with viral culture,12 and there have been many trials for 
clinical application of a multiple RT-PCR (mPCR) to specimens obtained 
from acute viral respiratory tract infections in children, hospitalized 
elderly, and exacerbated chronic obstructive lung diseases.6-8,14,25-28 
 Frequent association between respiratory viral infection and asthma 
exacerbation suggested the possibilities of viral sensitization among chronic 
asthmatics, and several studies had tried to detect virus specific 
immunoglobulin E (IgE) and related Th2 cytokines in these patients.29-34 
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Welliver, et al. reported RSV-specific IgE and histamines were detected in 
nasopharyngeal secretion from infected children.29-31 Dakhama, et al. 
showed RSV-specific IgE enhanced airway responsiveness on reinfection 
with RSV in newborn mice model.33,34 However, Toms, et al. reported that 
total IgE was low and RSV-specific IgE was undetected in sequential 
samples of nasopharyngeal secretion and sera of RSV infected children.35  
 Among RSV proteins, attachment protein G and fusion protein F play 
crucial role in infection.36,37 Okiro, et al. tried to identify infections with 
RSV by using specific IgG and IgA Enzyme-Linked Immunosorbent 
Assays with oral-fluid samples.38  Becker suggested that RSV G protein 
had highly conserved sequence containing T-cell antigenic domains which 
had the property of an allergen.39,40 Such association between virus 
proteins and allergens might be also applied to RSV proteins, and might 
be applied to detect RSV-specific IgE antibody.  
 We hypothesized that respiratory viral infection might affect asthmatics 
for prolonged period and viral-specific IgE might be detected in sputum 
from exacerbated asthmatics with recent upper respiratory infection, 
especially, RSV. 
 So, we investigated the respiratory viral detection rate, species, seasonal 
variation, and sequential dynamics with induced sputa from Korean adult 
asthmatics with acute exacerbation and control subjects with recent upper 
respiratory symptoms. For these investigations, we used multiplex-PCR 
methods, previously reported to be superior to conventional rapid shell 
vial culture,12,37 and analyzed the association between respiratory viral 
detection and asthma exacerbation. We also tried to apply conventional 
allergen-specific IgE CAP immunoassay, regarded as a quasi-standard 
method,41 to detecting sputum RSV specific IgE antibody and investigated 
the possible sensitization of RSV proteins. Major cytokines of Th1 
(interferon-gamma) and Th2 (interleukin (IL)-5 and IL-13) pathways were 
also measured for investigating the possible underlying mechanisms.
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II. MATERIALS AND METHODS
1. Recruitment of Patients and Control Subjects
 Asthmatic patients with acute exacerbation and related unscheduled visit, 
and non-asthmatic control subjects with recent (if possible < 21 days)  
upper respiratory symptoms, were recruited from the Allergy-Asthma 
Center of Severance Hospital (Seoul, Korea), for two years (from Dec, 
2008 to Dec, 2010). 
The inclusion criteria based upon the Global Initiative for Asthma 
(GINA) guideline42 were as followings: 1) asthmatic symptoms such as 
episodic breathlessness, wheezing, cough, and chest tightness in past 12 
months; 2) confirmation of the diagnosis of asthma by the measurements 
of lung function (spirometry or peak expiratory flow) assessing the 
severity of airflow limitation, its reversibility, and its variability; 3) the 
established asthma diagnosis by measurement of airway hyperresponsive- 
ness for patients with symptoms consistent with asthma.
Exacerbation of asthma (asthma attacks or acute asthma) was defined in 
consideration of the followings: 1) episodes of progressive increase in 
shortness of breath, cough, wheezing, or chest tightness, or some 
combination of these symptoms within 48 hours; 2) increase in asthma 
symptoms resulting in Clinic or ER visit, and hospital admission; 3) 
decreases in peak expiratory flow rate (PEFR) or FEV1; 4) usage of the 
primary therapies for exacerbations including repetitive administration of 
rapid-acting inhaled bronchodilators, the early introduction of systemic 
glucocorticosteroids, and oxygen supplementation within 48 hours. These 
are also based upon the GINA guideline.42  
 With included subjects, we reviewed their medical records and analyzed 
the results of induced sputum analysis, total IgE, and total eosinophil counts, 
spirometry, bronchial reversibility test, and methacholine challenge test. 
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2. Sputum induction and collection
Sputum inductions were performed promptly up to 3 times, if possible 
on Day 0, 7, and 28 for evaluating sequential dynamics for asthmatics 
with mild to moderate exacerbations. Control subjects, who visited with 
recent respiratory symptoms, also underwent same processes. In summary, 
hypertonic (3%) saline was applied to subjects through an ultrasonic 
nebulizer (Ultra-Neb 2000, DeVilbiss-Sunrise Medical, Somerset, PA, 
USA) for 20 min after spirometry and bronchodilator inhalation (400 mcg 
of salbutamol).43 We interrupted this process every 5 minutes for 
expectoration and collection of sputum and total induction time was 20 
minutes or less if pulmonary function fell.43 Several subjects with 
prolonged severe exacerbation, who could not underwent sputum induction 
procedure, expectorated sputa spontaneously. Sputum specimens underwent 
the processes including treatment with dithiothreitol (DTT) (SputolysinⓇ 
Reagent, EMD Millipore/Merck KGaA, Darmstadt, Germany), for further 
laboratory evaluations, according to the previously published protocols.43-45
Collected and processed sputum samples were divided into specific tubes 
for virus transportation and storage for later laboratory tests. Specimens 
were kept at 4°C, and if there any time-delay, we stored the samples at 
-70°C for long-term storage, before referring to the laboratories for 
multiplex RT-PCR, ImmunoCAP assay, and cytokine measures.
3. Multiplex reverse transcriptase-polychain reacation (mPCR)
 Multiplex RT-PCR (mPCR) with induced sputum specimens were 
performed for 12 respiratory virus species (Adenovirus, Rhinovirus A, 
Coronavirus OC43, Metapneumovirus, Influenza virus A and B, 
Coronavirus 229E/NL63, Parainfluenza virus 1, 2, and 3, RSV A and B) 
by the experts in Seoul Medical Research Institutes (Seoul, Korea). This 
was performed according to previously described protocols in other 
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studies.46,47 We performed RT-PCR using a Seeplex RV Detection Kit 
(Seegene Biotechnology Inc., Seoul, Korea). RNAs were extracted from 
530 µL of refrigerated induced sputum samples, using a MagMaxTM Viral 
RNA Isolation Kit (Ambion, Austin, TX, USA) with 5 µL of an internal 
control (SeeGene, Seoul, Korea). RNAs purified from induced sputum 
specimens were used for the synthesis of first-strand cDNAs by Moloney 
murine leukemia virus reverse transcriptase (200 U/µL; Promega, 
Madison, WI, USA). We used the Respiratory Virus Detection Kit-A and 
B (Seeplex RV detection kit, SeeGene, Seoul, Korea) for detecting eleven 
types of RNA and one type of DNA virus according to the 
manufacturer’s manual. In summary, PCR was performed in a final 
reaction volume of 20 µL containing 6 µL of cDNA, 4 µL of 5xRV 
Primer, and 10 µL of 2×Master Mix.46 The PCR protocol was 35 cycles 
at 94℃ for 30 sec, followed by 60℃ for 1.5 min, and 72℃ for 1.5 
min, followed by a 10 min final extension at 72℃.46 The separation of 
amplified PCR products were done on 2% agarose gels stained with 
ethidium bromide.46 The size markers, included in each kit, had the same 
lengths as those of amplicons for internal control and six viruses, and if 
a specimen demonstrated an amplicon of the same size as one of a 
marker band, we scored it as positive.46
4. Analysis of respiratory viral detection rate, sequential dynamics, and 
seasonal variation in induced sputum specimens
We analyzed the viral detection rate and its sequential dynamics of mPCR 
among exacerbated asthmatics and non-asthmatics with respiratory 
symptoms. We also analyzed the monthly and seasonal variation of 
respiratory viral detection in subjects and compared those with the 
nationwide respiratory viral infection monitoring data for 2 years in Korea.
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5. Comparison of clinical features between Respiratory Virus-detected Group 
and Non-detectors among asthmatics with exacerbations
 We reviewed the medical records of asthmatics with exacerbation. We 
compared, if available, the clinical features including demographics, induced 
sputum analysis, total IgE, and total eosinophil counts, spirometry, 
bronchial reversibility test, and methacholine challenge test between 
Respiratory Virus (and/or RSV)-detected group and Non-detectors. 
6. Measurement of RSV-specific IgE
 A. Preparation of RSV stock
 RSV stock was prepared according to protocols described in the 
previous study.48 Briefly, Propagation of RSV A2 strain was done with 
HEp-2 cells (ATCC, Manassas, VA, USA) in DMEM (Life Technologies, 
Gaithersburg, MD, USA) with supplements including 3% heat-inactivated 
FCS, 2 mM glutamine, 20 mM HEPES, nonessential amino acids, 
penicillin, and streptomycin. Considering the maximal cytopathic effect of 
infected HEp-2 cells, viral harvesting was performed with 4~5 days’ 
interval from cell infections. In brief, disrupting RSV infected cells by 
freeze-thawing (3 cycles) was followed by sonication for 1 min, and 
centrifugation at 300×g for 10 min, serially. The collected supernatant, 
combined with the cleared supernatant from the infected HEp-2 culture, 
was centrifuged at 75,000×g for 1 hour. The pellets, resuspended to 
serum-free MEM with 25-gauge needle, were underwent brief sonication. 
Final titers were measured by standard plaque assay.
 B. Construction of RSV G protein core fragment (Gcf)
 RSV G protein core fragment (Gcf) was constructed by the methods of 
the previous study.48 Concisely, the amplification of coding sequence of 
RSV G protein spanning from amino acid residues 131 to 230 (RSV A2 
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strain) from cDNA was performed by PCR, and cloning into the EcoR I 
and Hind III sites of pET-21d (+) vector (NovagenⓇ, EMD 
Millipore/Merck KGaA, Darmstadt, Germany) were done. Transforming 
the constructed plasmid into E. coli BL21 (DE3) (NovagenⓇ, EMD 
Millipore/Merck KGaA, Darmstadt, Germany) was followed by inducing 
overexpression with isopropyl β-D-1-thiogalactopyranoside (IPTG, Takara, 
Shiga, Japan). Centrifugation, suspension with binding buffer (20 mM 
Tris, 0.5 M NaCl, pH 8.0), and sonication of bacterial cells were done. 
Soluble and insoluble proteins were separated by centrifugation (at 
40,000×g for 20 min). Further purification were performed with the clear 
supernatants. Purification of expressed G protein core fragment was done 
using affinity chromatography with HisTrap column (GE Healthcare, Little 
Chalfont, UK). Then, loaded proteins, washed by binding buffer 
containing 20 mM imidazole, were eluted using the elution buffer (500 
mM imidazole, 20 mM Tris, 0.5 M NaCl, pH 7.4). Further purification 
of eluted protein fractions were done with Superdex-75 columns after 
equilibration with PBS (GE Healthcare, Little Chalfont, UK). For 
endotoxin removal, the purified protein was treated with 1% TritonTM 
X-114 (Sigma-Aldrich Co. LLC., St. Louis, MO, USA) for 30 min at 
4°C and, then, incubated at 37°C for 20 min. The phase containing 
endotoxin was removed using centrifugation. These processes were 
repeated for five cycles. For removal of residual TritonTM X-114, the 
protein was incubated with SM-2 beads (Bio-Rad, Hercules, CA, USA) 
for 2 hours at 4°C,  and it was filtered through spin-X column (Costar, 
Washington, DC, USA). The endotoxin levels in the protein preparation 
were determined with the limulus amebocyte lysate (LAL) assay kit 
(Lonza, Switzerland) according to the manufacturer's mannual. The 
endotoxin level was less than 5 EU/mg. Measurement of protein 
concentrations was performed with Bio-Rad Protein assay (Bio-Rad 
Laboratories, CA, USA). Additional concentration was measured with the 
centrifugal filter, Amicon® ultra (Millipore, Bedford, MA, USA). For 
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visualization of the purification, samples were resolved on 15% SDS-PAGE 
and were stained using Coomassie Brilliant Blue. Western blottings for 
verifying the purity of Gcf were performed with RSV-specific goat 
polyclonal antibody (United States Biological, Salem, MA, USA) and 
HRP-conjugated anti-goat Ig antibody (Zymed Laboratories, CA, USA). 
Storage of the purified proteins was done at −80°C in aliquots until use.
 C. ImmunoCAPTM specific IgE measurement (CAP assay)
 ImmunoCAPTM(CAP)　specific IgE were measured by Phadia®250 system 
(Thermo Fisher Scientific, Inc., Waltham, MA, USA) according to the 
manufacturer’s protocols and the previous studies.49,50 
 Briefly, the lysates of RSV crude extracts and RSV recombinant G 
protein core fragments were biotinylated using the Biotin Protein Labeling 
Kit (Roche Diagnostics GmbH, Mannhein, Germany) according to the 
manufacturer’s manual, and were diluted in sample diluents at 50 µL. 
Then, each dilution was applied to the PBS-prewashed Streptavidin 
ImmunoCAPTM (Thermo Fisher Scientific, Inc., Waltham, MA, USA). 
These CAPs were incubated for 30 minutes at room temperature and 
washed with PBS. Then, those CAPs were used for specific IgE 
measurements with the sputum supernatants by CAP assay according to 
the manufacturer’s protocol using rabbit anti-IgE labeled with β-galactosidase 
and 0.01% 4-methylumbelliferyl-β-D-galactoside and detecting fluorescence 
by Phadia®250 system expressing results as fluorescence units (FU).49,50 
CAP assay is routinely performed in parallel with a standard curve 
allowing conversion from FU to IgE antibody titers in kilo international 
units per liter.49 According to the previous report, one international unit 
of IgE is equivalent to 2.4 ng of IgE.49 In this study, CAP assay 
demonstrated specific IgE titers as international unit per milliliter (IU/mL, 
i.e. kU/L). 
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7. ELISA for Interferon-gamma, IL-5, and IL-13
 Total 50 sputum supernatants collected in an Eppendorf tube and 
centrifuged. By ELISA, Interferon-γ (BD OptEIA™ Human IFN-γ ELISA 
Kit II, Becton, Dickinson and Company (BD), Franklin Lakes, NJ, USA), 
IL-5 and IL-13 (Quantikine Human IL-5 and IL-13 ELISA kit, R&D 
systems, Inc., Minneapolis, MN, USA) were measured according to the 
manufacturers' protocols.
 Briefly, 96-well plates were coated overnight with 100 µl/well of 
capture antibodies. Dilution of the purified anti-cytokine capture antibody 
to 1-4 µg/mL in binding solution were done. Then, 100 µl of diluted 
antibody were added to the wells of an enhanced protein-binding ELISA 
plate. The plates were sealed to prevent evaporation and were incubated 
overnight at 4°C. Blocking process was done by bring the plate to room 
temperature (RT), removing the capture antibody solution, and blocking 
non-specific binding by adding 200 µl of Blocking Buffer per well. The 
plates were sealed and incubated at RT for 1-2 hours. Then, washing (≥ 
3 times) with PBS/Tween® was followed. The standards and samples 
(diluted in Blocking Buffer/Tween®) were added at 100 µl per well. 
Sealed plates were incubated again for 2-4 hours at RT or overnight at 
4°C. Wash (≥ 4 times) with PBS/Tween® were followed. The biotinylated 
anti-cytokine detection antibody was diluted to 0.5-2 µg/ml in Blocking 
Buffer/Tween®. Adding 100 µl of diluted antibody to each well was 
done. The plates were sealed and incubated for 1 hour at RT. Washing 
with PBS/Tween® were repeated (≥ 4 times). The avidin-horseradish 
peroxidase (Av-HRP) conjugate (cat. no. 554058) or streptavidin-HRP 
(cat. no. 554066) or other enzyme conjugate were diluted to its 
pre-titered optimal concentration in Blocking Buffer/Tween®. Addition of 
100 µl per well was done. The plates were sealed and incubate at RT 
for 30 min. Washing with PBS/Tween® was repeated (≥ 5 times). TMB 
(cat. no. 555214) according to directions or ABTS were used as a 
substrate. ABTS Substrate Solution was thawed within 20 min of use. 
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Adding 100 µl of 3% H2O2 per 11 ml of substrate and vortexing were 
done. Immediate dispensing of 100 µL into each well was followed. 
Incubation at RT (5-80 min) were done for color development. Finally, 
the optical density (OD) for each well was measured with a microplate 
reader (Thermo Multiskan® Ex, Vantta, Finland) set to 405 nm.
8. Statistical Analysis
 Statistical analyses, data processing, and graphic works for tables and 
figures were performed using R version 3.1.1 (R Core Team (2014), 
Vienna, Austria),51 and Microsoft® Office Excel 2007 (Microsoft Corpora-
tion, Seattle, WA, USA). 
 For normally distributed data, Student’s t-test, Pearson’s chi-square test, 
and Pearson’s correlation test were performed, and for non-parametric 
analyses, Wilcoxon rank-sum test (Mann-Whitney U-test), Kruskal-Wallis 
test, and Spearman’s correalation test were used. Receiver Operating 
Characteristics (ROC) curves for related statistical analyses including 
cutoff value, sensitivity, and negative predictive value were also be 
done.41,51-53 In all cases, a two tailed p-value < 0.05 was considered to 
be statistically significant. 
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III. RESULTS
1. Demographics of enrolled subjects
 Among the 139 sputum collections (Figure 1), total 132 sputum samples 
from 70 subjects (M/F= 27/43, Age= 52.2±15.5 year-old (18.0~77.0)) 
were included for mPCR during about two years (Dec 2008 ~ Dec 
2010). Seven of 139 collections were excluded for incomplete process or 
insufficient amounts of samples. In the 70 subjects, 19 completed 2 times 
and 24 accomplished 3 times of sputum collection processes.  
 Among 70 enrolled subjects, asthmatics were 60 and control groups 
were 10 (chronic cough 6, bronchitis 2, and COPD 2).   
 
Figure 1. Time series of sputum collections (n=139). 
 Among the enrolled groups, 60 subjects had the available baseline results 
of pulmonary function test (PFT) and demonstrated 76.2±21.8% (2.1±0.960 
L) of FEV1, 84.4±19.5% (2.8±1.1 L) of FVC, and 73.2±10.7% of 
FEV1/FVC. Sputum eosinophil fraction (n=50) were 17.3±20.7%, but the 
results of methacholine challenge test, and screening tests for atopy 
including skin prick test and phadiatop were available in only a few. 
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 2. Respiratory viral detections in multiplex RT-PCR (mPCR)
  Among 132 induced sputum samples, total 15 respiratory viral 
detections in mPCR were observed in asthma patients and COPD controls 
(n= 13, and 2, respectively).   
Figure 2. The results of multiplex Reverse transcriptase-Polychain 
Reaction (mPCR) for detection of 12 species of respiratory viruses in the 
sputa (n=132, partial data shown). Red rectangle: detected band.
  
 Viral detection rates were 11% (14/132) among the sputum samples and 
17% (12/70) of the subjects. RSV was the most frequently detected 
species among those (53%, 8/15) and the asthmatic subjects (54%, 7/13) 
(Figure 2 and Table 1). Seasonal variation were also observed (Table 1). 
For example, One multiple and two sequential detections were observed 
in three asthmatics (Table 1). 
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Table 1. Sequential viral detection by multiplex RT-PCR for 12 viral species
Subjects 
ID
Visit for sputum induction
Detected date
1st 2nd 3rd
6 CoronaV April, 2009
7 RSV A Negative Negative May, 2009
16 RSV A Negative Negative March, 2009
17 RSV A CoronaV April, May, 2009
18 RSV A Negative May, 2009
19 Negative RSV A Negative December, 2009
20 RSV A, B* Negative Negative December, 2009
21 Negative RSV A Negative October, 2010
22 ADV Negative Negative April, 2009
23 IFV B MPV April, May, 2009
24 ParaIFV-2 September, 2009
25 Negative Negative IFV A March, 2010
*: multiple detection; blank: no visit/sputum-induction; gray zone: COPD patients
(ADV: adenovirus, CoronaV: coronavirus OC43 and 229E/NL63, IFV A: influenza virus A, IFV 
B: influenza virus B, MPV:　 metapneumovirus, ParaIFV-2: parainfluenza virus 2, RSV A: 
respiratory syncytial virus A, RSV B: respiratory syncytial virus B)
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　 Cough,n=5
COPD,
n=2
Asthma, n=18
Virus(-), n=8
Virus(+), n=10
RSV(-), n=4 RSV(+), n=6
Sex(M/F) 1/4 2/0 6/2 1/3 2/4
Age(year) 41.6±15.0 55.0±2.8 48.8±18.4 62.0±4.3 57.3±11.6 
BMI(kg/m2) 22.9±2.2 21.4±0.2 24.4±2.8 24.8±2.2 28.2±2.7 
PFT 
(base- 
line) 
FEV1 
(pred%) 
2.8±0.9 L 
(103.0±11.8%) 
1.2±0.5 L
(39.1±17.7%) 
2.4±0.8 L 
(71.6±16.9%) 
1.8±0.3 L 
(77.7±15.3%) 
1.6±0.9 L 
(58.7±21.9%) 
FVC 
(pred%) 
3.3±1.0 L 
(103.6±9.4%) 
2.1±0.7 L
(54.1±20.9%) 
3.3±1.0 L 
(82.8±15.1%) 
2.4±0.3 L 
(86.4±13.1%) 
2.2±1.1 L 
(69.1±19.2%) 
FEV1/ 
FVC 83.6±4.7% 57.0±4.3% 70.4±8.2% 73.9±6.3% 69.0±12.0% 
Eosinophil 
(sputum) 3.8±6.9% 4.00% 13.3±10.7% 32.5±38.4% 18.3±20.5% 
3. Demographics of selected sputum samples for sequential dynamics, 
RSV and its Gcf specific IgE and cytokine measurements
  Among 132 sputum samples, 50 specimens from 25 subjects were 
selected (Table 2) for sequential dynamics (Figure 3), RSV and its Gcf 
specific IgE, and cytokine measurments according to the following 
criteria. 
1) positive viral detection in mPCR; 2) controls matching to 1) in 
consideration of seasonal variation and diagnosis; 3) sufficient amounts 
for above investigations; 4) if possible, complete initial clinically relevant 
data; 5) if possible, accomplished sequential collections and time intervals 
 
 The demographic data of above selected groups according to diagnoses 
and viral detections in mPCR were shown in Table 2. 
Table 2.  Demographics of selected sputum samples for sequential dynamics, 
RSV and its recombinant G protein core fragment (Gcf) specific IgE and 
cytokine measurements (n=50 samples from 25 subjects)
mean±standard deviation; pred%: percent of predicted value
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 Sequential dynamics showed that viral detections were only observed 
among subjects with chronic obstructive lung diseases (asthma and 
COPD) (Figure 3). RSV detections in mPCR were observed on the first 
visit day (5/7), and only 2 cases were detected with 7 days to 28 days 
of intervals from the first visit, respectively. The other viruses detected in 
mPCR were observed on the first day (4/7), about 1 months (2/7), and 3 
months (1/7, maybe, newly infected), in turn.   
 
Figure 3. Sequential dynamics of respiratory viral detections in mPCR 
among the selected sputa (n=50) from subjects (n=25) according to 
sampling interval and diagnoses. Days: sampling interval, red circle: viral 
detected, yellow rectangle: RSV detected, BAE: bronchial asthma with 
exacerbation, RSV(+): RSV detected, V(+): respiratory virus detected.
4. RSV and Gcf specific IgE measurements
 We applied conventional allergen-specific IgE CAP immunoassay to 
detecting RSV and its Gcf specific IgE antibody in sputum, and 
investigated the possible sensitization of RSV proteins. The whole data of 
these CAP specific IgE measurements were showed in Table 3.
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Table 3. CAP measurement of crude RSV and its Gcf specific IgE (n=50 
samples from 25 subjects; See Figure 3. legend for additional explanation.) 
Subjects
ID
Diagnosis/
Viral 
Detection
crude RSV whole 
antigen sIgE (CAP) RSV Gcf sIgE (CAP) Detected viral 
species 
(by mPCR)　kU/L Optical Density kU/L
Optical 
Density
1 Cough Control 0.08 46 0.22 111 Negative
2 Cough Control 0.08 49 0.23 115 Negative　
3 Cough Control 0.06 41 0.22 109 Negative
4 Cough Control 0.08 48 0.31 151 Negative
5 Cough Control 0.05 33 0.33 162 Negative
6 COPD/V(+) 0.06 41 0.35 168 CoronaV
7 COPD/RSV(+) unperformed unperformed unperformed unperformed RSV A*
0.05 34 0.12 68 Negative
0.05 36 0.15 78 Negative
8 BAE  only 0.05 32 0.18 93 Negative
0.05 36 0.18 92 Negative
0.05 35 0.17 89 Negative
9 BAE  only 0.09 53 0.30 147 Negative
0.06 38 0.19 97 Negative
0.08 48 0.20 103 Negative
10 BAE  only 0.08 49 0.30 148 Negative
0.08 48 0.29 141 Negative
0.09 54 0.28 138 Negative
11 BAE only 0.06 38 0.13 71 Negative
12 BAE only 0.07 45 0.31 152 Negative
13 BAE  only 0.05 35 0.31 151 Negative
0.03 26 0.24 119 Negative
0.05 34 0.32 155 Negative
14 BAE only 0.06 38 0.34 166 Negative
15 BAE  only 0.05 36 0.28 140 Negative　
0.07 42 0.26 130 Negative
16 BAE/RSV(+) 0.08 47 0.17 91 RSV A
0.08 47 0.29 142 Negative　
0.12 67 0.35 168 Negative
17 BAE/RSV(+) 0.08 46 0.32 157 RSV A
0.11 60 0.30 149 Corona
18 BAE/RSV(+) 0.06 39 0.12 68 RSV A
0.05 36 0.13 70 Negative　
19 BAE/RSV(+) 0.08 47 0.33 161 Negative
0.04 30 0.34 166 RSV A
0.06 37 0.32 158 Negative
20 BAE/RSV(+) 0.05 34 0.29 142 RSV A,B
0.05 35 0.30 146 Negative　
0.05 34 0.29 142 Negative
21 BAE/RSV(+) 0.52 244 0.52 245 RSV A
0.07 42 0.36 174 Negative　
0.04 31 0.35 169 Negative
22 BAE/V(+) 0.06 40 0.28 139 ADV
0.06 39 0.25 125 Negative　
0.08 46 0.26 128 Negative
23 BAE/V(+) 0.06 38 0.21 106 IFV B
0.08 46 0.27 133 MPV
24 BAE/V(+) 0.04 29 0.12 64 ParaIFV2
25 BAE/V(+) 0.05 33 0.29 144 Negative　
0.05 33 0.29 144 Negative
0.04 29 0.28 139 IFV A
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 Crude RSV specific IgE were detected in several subjects but failed to 
show statistical differences between the subject groups. Among asthmatics, 
CAP specific IgE to Gcf (Gcf-sIgE) in sputa supernatant was higher in 
the subjects with RSV detection by mPCR (p=0.012) (Figure 4). 
   p=0.012 
Figure 4. Comparison of CAP RSV recombinant G protein core fragment 
specific IgE　 (Gcf-sIgE)　 measurement among the exacerbated adult 
asthmatics between the RSV undetected (-) and ever detected (+) groups.
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5. Cytokine measurements (Interferon-gamma, IL-5, and IL-13)
 Major Th1 (interferon-gamma) and Th2 (IL-5 and IL-13) cytokines were 
measured with the sputum supernatants from the subjects for investigating 
possible underlying mechanisms. Interferon-gamma was detected in the 
several subjects but failed to show statistical differences between the 
subject groups (Figure 5A). Among the exacerbated adult asthmatics, IL-5 
in sputa supernatant was higher in the subjects with RSV detection by 
mPCR (p=0.013) (Figure 5B). However, IL-13 was detected in only one 
control subject (data not shown) and could not be statistically analysed. 
- 22 -
   p=0.013
A
B
Figure 5. Comparisons of Interferon (IFN)-gamma (A) and IL-5 (B) 
measurements among the exacerbated adult asthmatics between the RSV 
undetected (-) and ever detected (+) groups.
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6. Receiver operating characteristic (ROC) curve analysis for CAP RSV 
Gcf-sIgE measured asthmatics with exacerbation
 In the ROC analyses, CAP　RSV Gcf-sIgE for the exacerbated asthmatics 
with or without ever detection of RSV by mPCR showed the fair 
accuracy of 0.73 measured by the area under the ROC curve (AUC) 
(95% confidence interval (95% CI) 0.47-0.82; sensitivity (SE) 81.3%, 
specificity (SP) 65.4%, positive predictive value (PPV) 59.1%, negative 
predictive value (NPV) 85.0%), and demonstrated the best coordinate 
cutoff value (the highest value that sensitivity and specificity can be 
jointly attained) at 0.285 kU/L (Figure 7).41,51-53 
Figure 6.  Receiver operating characteristic (ROC) curve analysis of CAP 
RSV Gcf-sIgE for the exacerbated asthmatics with or without ever detection 
of RSV by mPCR (area under curve (AUC) 0.73, 95% confidence Interval 
0.47-0.82; sensitivity 81.3%, specificity 65.4%, positive predictive value 
59.1%, negative predictive value 85.0%; The best coordinate cutoff value of 
RSV Gcf-sIgE discriminating the exacerbated asthmatics with or without 
ever detection of RSV by mPCR was 0.285 kU/L). 
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IV. DISCUSSION
 In this study, RSV was the most commonly detected species by mPCR 
for 12 respiratory viral species, using sputum samples induced from lower 
airways of adult asthmatics with acute exacerbation and control subjects 
with upper respiratory symptoms. In the subgroup analysis, RSV was also 
the most frequently detected viral species among acutely exacerbated 
asthmatics. Conventional allergen-specific IgE CAP immunoassay can be 
applied to detect crude RSV and its recombinant G protein core fragment 
specific IgE antibodies in sputum specimens. Among the asthmatics with 
acute exacerbation, RSV ever-detected (by mPCR) subjects showed higher 
Gcf-sIgE and IL-5 levels than the RSV-undetected group. These results 
suggest clinical clues for the mechanism of respiratory viral infection  
induced acute exacerbations in adult asthmatics, which has not yet been 
fully evaluated.
 The overall respiratory viral detection rate of this study was 11.4% 
among the 132 induced sputum samples (118 from asthmatics and 14 
from control subjects with recent upper respiratory symptoms). This 
detection rate seems to be lower than the previous studies using PCR 
techniques.8,54-56 Early studies had reported low respiratory viral detection 
rates, for they used virus detection method with low sensitivity for 
rhinoviruses and corona viruses, causing the majority of colds.2  For 
example, Beasly, et al. reported only 10% of viral identification rate 
among 178 asthma exacerbations.57 
 Later, the role of viruses in asthma exacerbations were investigated by 
multiplex PCR technique in several studies,54-56 and then more rapid 
multiplex PCR was developed.24 With nasopharyngeal swab samples from 
elderly subjects, Falsey, et al. reported higher RSV detection rates of 
RSV strain-specific RT-PCR assay and serologic enzyme immunoassay 
using IgG responses to purified RSV glycoproteins than those of viral 
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culture methods.8 The previously reported viral detection rate in 
respiratory specimens from children with asthma exacerbation ranged from 
38% to 63.1%,55,56 but control group showed 23.4% of viral detection 
rate.56 In adult patients, acute asthma showed 41% of viral detection rate 
and near-fatal asthma demonstrated 59% of viral detection rate.54 
 Nationwide respiratory viral monitoring data of the overlapping periods 
with this study has been opened to public by the Korea Influenza and 
Respiratory Surveillance System (KINRESS) and the Surveillance network 
for severe Lower Respiratory tract Infection in infants and children 
(SLRI) sponsored by Korea Center for Disease Control and Prevention 
(KCDC).58,59 This surveillance had been performed by mPCR/RT-PCR for 
9 respiratory viral species (Influenza virus, Adenovirus, Parainfluenza 
virus, RSV, Enterovirus, Bocavirus, Coronavirus, Rhinovirus, and 
Metapneumovirus) using throat swab from adult outpatients visited with 
common cold symptoms, and  nasopharyngeal aspirates from children 
(under 5 years of age) admitted with respiratory infections.58 The 
KINRESS and the SLRI reported 52.9% and 73.7% of viral detections 
rates in 2010, respectively.58 
 The relatively low viral detection rate of this study may be caused by 
differences in collection sites (upper vs. lower respiratory tract) and 
process of specimens (dilution factor, RT-PCR methods, etc.), and clinical 
characteristics of subjects groups (general population vs. mainly, 
asthmatics). It should be considered that this study was performed with 
outpatients who could undergo sputum induction procedures collecting 
mainly lower airway specimens. 
 The results in this study showed seasonal variations of respiratory viral 
detection frequency and species in sputum samples from acutely 
exacerbated asthmatics and control subjects. The respiratory detections 
including RSV showed two peaks in the seasons of spring (March to 
May) and autumn (September to December), and these findings 
corresponded to the previously mentioned KCDC surveillance reports 
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during the periods overlapped to this study.58,59 
 Among the sputum samples from the asthmatics with acute exacerbation, 
RSV detection rate was 5.9% (7/118), and RSV was the most frequently 
found viral species in this study. According to the nationwide KCDC/ 
KINRESS surveillance reports from 2010 to 2012, RSV showed average 
4.5% of detection rate, and ranked only the 4th frequently detected viral 
species next to human rhinovirus (15.4%), influenza virus (14.0%), and 
adenovirus (8.3%) among general population with respiratory symptoms.59  
The differences of viral detection rates between this study and nationwide 
surveillance enrolled general subjects suggests that RSV infection may be 
more closely associated with acute asthma exacerbation than the other 
respiratory viral species. 
 RSV had not been recognized as a potentially serious problem in older 
adults until the 1970s, however, RSV outbreaks in long-term care 
facilities arouse public opinion that the RSV might  be an important 
cause of illness in community-dwelling elderly.60-62 There had been 
several reports that RSV accounted for deaths in elderly, and it was 
assumed that approximately 10,000 deaths annually in elderly (over the 
age of 65 years) were associated with RSV infections in the United 
States.8,63-67 Two meta-analyses showed that RSV has caused more than 
3.4 million episodes of acute lower respiratory infections in 2005, while 
seasonal influenza caused more than 20 million episodes of such 
infections worldwide in 2008.68,69 Gaut ER, et al. calculated disease 
burden of the most commonly detected viruses among hospitalized 
patients using the disability adjusted life year model, which the World 
Health Organization endorsed.70 The calculation showed strikingly different 
disease burden profiles in children and adults, for example, adenovirus 
was among the leading causes of respiratory presentation in children but 
not adults.70 However, RSV and influenza A were consistently observed 
as one of the greatest causes of disease regardless of sampled 
population.70
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 Lysholm, et al. tried to characterize the viral microbiome by meta- 
genomic sequencing using nasopharyngeal aspirates from the patients with 
severe lower respiratory tract infections, and reported that Paramyxo- 
viridae (RSV, metapneumovirus, and parainfluenza virus), Picornaviridae 
(rhinovirus), and Orthomyxoviridae (influenza virus) were the 3 most 
common causes for severe lower respiratory tract infections in children, 
and some adults.71 Among those, the most abundant viral family was 
Paramyxoviridae (38%: RSV 80%, metapneumovirus 15%, and parainflu- 
enza virus 4%), which outnumbered Picornaviridae (31%: rhinovirus A 
65%, B 0.1%, and C 35%).71 It was also reported that rhinoviruses were 
one of significant pathogens in all groups except those aged 16-64 years.70
 Considering these previous studies, no detection of rhinovirus species in 
this study may be partially caused by the differences in ages of subjects, 
type and collecting sites of specimen, morbid diseases, and limited mPCR 
detection confined to rhinovirus A, but it still remains to be more 
elucidated.    
 We postulated that respiratory viral infection might affect asthmatics for 
prolonged period, however, this study failed to show any prominent and 
prolonged sequential dynamics of respiratory viral detections. It is still 
controversial whether respiratory viruses are simple exacerbaters or potent 
causes with latency and persistence of asthma. Several studies reported that 
respiratory viruses, especially RSV, showed such latency and persistence in 
chronic obstructive lung disease including asthma, even despite T cell 
immunity.25,26 However, Wood, et al. suggested that persistent airway 
obstruction after respiratory viral infection was not associated with airway 
inflammation,21 and van Elden, et al. suggested that enhanced severity of 
virus associated lower respiratory tract disease in asthmatics might not be 
associated with delayed  clearance (i.e. persistence) and increased load of 
respiratory viruses in the upper airway.22
 The demographic data of selected groups according to diagnoses and 
viral detections in mPCR (Table 2) showed several interesting findings. 
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Although these findings were not statistically significant due to the 
limited sample size (50 samples from 25 subjects), the subgroup of the 
RSV detected asthmatics showed a trend of higher body mass index 
(BMI) than the RSV undetected asthmatics or control subjects (p=0.07). 
The RSV detected asthmatics also tended to have lower baseline FVC 
and FVC % predicted value than the RSV undetected asthmatics or the 
control subjects (p=0.07 and 0.13, respectively). These findings might 
suggested that acute exacerbations in the asthmatics with high BMI and 
low baseline lung function tend to be associated with RSV infections. 
 Several previous studies have suggested that increased body weight is 
associated with changes in certain immune functions, and less immune 
response to vaccines,72 and obese patients frequently experience worse 
outcomes relating to infectious diseases than the thinner counterparts.73 
Zimmerman, et al. reported that higher BMI was associated with 
respiratory influenza infection, though such finding was not prominent in 
RSV infection.74  Furthermore, decreased lung function may be associated 
with prior events of a childhood RSV infection and its sequela.9,75 
Recently, Backman, et al. carried out a 30-year follow-up on 43 adults 
admitted for RSV lower respiratory tract infections (27 for bronchiolitis 
and 16 for pneumonia), and such hospitalization in infancy was related to 
an increased risk of permanent obstructive reduction of lung function in 
adulthood.76,77 They also reported higher asthma risk after hospitalization 
for bronchiolitis.76,77
 To find the targets of viral infection to a host-protective mechanism in 
early life, which increases susceptibility to allergic disease, Krishnamoorthy, 
et al. has suggested that early infection with RSV impairs regulatory T 
cell function and increases susceptibility to allergic asthma with infant 
mouse models.78 In repeated infection of infant mice, they observed that 
RSV induced a Th2-like effector phenotype in Treg cells and attenuated 
tolerance to an unrelated antigen (i.e. allergen) by promoting a Th2-type 
inflammatory response in the lung.78 
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 Does RSV protein specific IgE exist, like allergens specific IgE? As 
previously mentioned, there have already been several investigations prove 
the existence of RSV-specific IgE existence using ELISA methods with in 
nasopharyngeal secretion, and sera from infected children and mice 
models.29,30,31,33,34 However, to our knowledge, this study is the first applica-
tion of conventional ImmunoCAP system to detect RSV and its Gcf 
specific IgE antibodies, using sputum samples. As previously mentioned, 
this system is clinically available and established as a quasi-standard in 
immunoassays for serum allergen-specific IgE.41 By this approach, we tried 
to demonstrate the possible sensitization of RSV proteins, like inhalant 
allergens. As a result, we could detect RSV and its Gcf specific IgE 
antibodies in sputum samples from the subjects. One of them with RSV 
detection by mPCR, showed even higher IgE level (0.52 kU/L) than 
conventional lower cutoff value for serum samples (0.35 kU/L).49,50 
 Does these findings have any clinical meaning and reflect the need of 
real clinical situations? Though there has been previously mentioned 
controversies in the existence of RSV-specific IgE detection in 
nasopharyngeal secretion from the RSV infected subjects,35 our study 
confirmed the existence by clinically available and standardized specific 
IgE detecting immunoassay system. Furthermore, recombinant RSV G 
protein core fragments may be used better in the measurement of 
RSV-specific IgE than total crude RSV antigens, because recombinant 
protein fragments can be constructed by engineered technique which is 
more suitable for industrial productions. Such future possibilities of clinical 
application will be more discussed in the latter part. 
  Only a few of asthmatics among RSV detected by mPCR, showed 
higher than conventional cutoff range for serum samples. But the 
asthmatics with ever detection of RSV by mPCR, showed higher RSV 
recombinant G protein core fragment specific IgE and IL-5 levels than 
RSV undetected asthmatics. It can be assumed that the possible sensitizer 
for some of acutely exacerbated asthmatics is more likely the comprising 
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protein like G protein than crude RSV whole antigens. Such component 
resolved diagnostic approach using the recombinant allergens has been 
common in allergen investigations and has been strengthened by 
molecular and microarray technique,41,79-81 and can be applied to 
investigation of viral protein sensitization and its impact on asthma 
exacerbation. 
 This study has several strengths and limitations as followings. 
 This investigation was performed with adult asthmatic exacerbations and 
their induced sputum specimens from lower airways rather than 
nasopharyngeal aspirates. This is an outpatient-based study reflecting real 
clinical  situations. Although there have been several Korean domestic 
studies using PCR technique for respiratory viral detection with sputum 
samples from upper and lower airways, most of those are limited to 
children,46,47,82 or small sized adult groups mixed asthmatics with other 
chronic obstructive lung disease patients.83 Therefore, the results of this 
study can suggest more clinical clues for the association of respiratory 
viral infections with adult asthma exacerbation. 
 However, limited sample size from single asthma-allergy center of single 
institution and no inclusion of healthy controls are the weak points of this 
study. Considering the limited outpatient based study settings, it was 
inevitable and could be the possible cause of selection bias, that this 
study enrolled mainly asthmatic subjects with acute exacerbations and only 
small sized controls with recent respiratory symptoms. This weakness was 
accompanied by frequent loss to follow up for serial viral dynamic 
observations, and resulted in the limited available clinical data.
 Because of the difficulties in sputum induction procedures, the collected 
amount of some sputum samples were not enough. This shortage of 
sputum amounts caused the limitations in measuring enough times and 
types of IgE and cytokine, as the prior respiratory mPCR requiring 
considerable amounts of specimens. 
 As previously discussed, respiratory detections showed seasonal variations 
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and those were also overlapped with the inhalant allergen peak seasons. 
So it is still undistinguishable whether respiratory viruses are direct cause, 
simple trigger assisting allergens, or even just bystander of allergic 
inflammations. This point is the insuperable limitation and discussion 
points of this study. However, Cheung, et al. claimed that there had been 
several evidences for a post-viral "atopic cycle" that could explain the 
development of multiple allergen sensitization, and supported the "viral 
hypothesis", and, in particular, the role of RNA viruses, including RSV, 
in the development of atopic diseases.84
 Busse, et al. suggested that deficiencies in antiviral activity and the integrity 
of the airway epithelial barrier could make asthmatics prone to have severe 
respiratory viral infections of the lower airway, increasing the risk of 
exacerbation.85 We can also consider the possibility of cross-reactions between 
viral antigens and inhalant allergens, like in the pollen cross-allergenicity.86 
Interestingly, Becker suggested that gp41 heptad repeat 2 (HR2) possesses an 
amino acid domain that resembles the allergen domain in Aspergillus 
fumigatus Asp f 1 protein.87 
 Although, to our knowledge, this study is the first trial to measure the 
specific IgE to crude RSV whole antigens and its recombinant G proteins 
core fragments by conventional ImmunoCAP system, there were several 
limitations due to the unestablished conditions of this original approach. 
We tried to performed the CAP assay according to the manufacturer’s 
manual and the previously reported studies using serum samples.49,50 
Although there were several proposals for measurement of total and 
specific IgE in sputum,88-90 sputum processing for ImmunoCAP system is 
still not fully established. So there must be limitations related to 
conditioning, calibration, unestablished standard and reference range, 
titration and quantification, sputum processing and dilution effects. For 
example, it had been suggested that sputum processing with too high 
concentration of dithiothreitol (DTT) might reduce the disulfide bonds in 
the IgE-molecule.88-90 These limitations should be considered in mPCR 
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detection performance, either.  
 But our study also suggests some clinical clues, like a possible cutoff 
value of RSV Gcf-sIgE for discriminating the exacerbated asthmatics with 
or without ever detection of RSV by mPCR, suggesting the possible RSV 
infection experience. The ROC analyses for CAP sputum RSV Gcf-sIgE 
of the exacerbated adult asthmatics, showed fair accuracy (AUC 0.73) 
and demonstrated good sensitivity (81.3%) and negative predictive value 
(NPV) (85.0%) at the best coordinate cutoff value (0.285 kU/L).51-53  
These results might suggest that RSV Gcf-sIgE could be the fair to good 
screening tool to identify the RSV associated asthma exacerbation, that 
might have different and more severe clinical features than the others. 
 There are another limitations in this investigation. This study was performed 
with only sputum specimens, serum samples as powerful references were 
unable to draw from subjects. Other major serologic parameters of 
conventional studies for virology, like IgG, IgG4, and IgA, were unmeasured. 
These should have been performed like the previous report.91 However, 
Khan, et al. asserted in their review with a total of 1,643 publications 
that only several studies focused on IgE and the viral risk of asthma, 
and they emphasized the development of future therapies for post-viral 
atopic disease related to antiviral IgE.92 
 Recently, the existence and importance of local IgE in nasal mucosa of 
patients with allergic rhinitis, very closely associated disease entitity with 
asthma, have been suggested.93,94 Baba, et al. reported local class 
switching to IgE, production of IgE and IgE localization to the surface 
of mast cells in eosinophilic chronic rhinosinusitis among the Japanese 
population.93 Meng, et al. suggested that immunoglobulin free light chain 
might play an important role in inducing inflammation of local nasal 
mucosa in the patients with allergic rhinitis and nonallergic rhinitis.94 
Taken together, IgE detection in sputum samples locally collected from 
lower airways may have clinical significance, to the certain extent, even 
without serologic evaluation.  
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 Limited cytokine measurement is also a critical weakness of this study. 
We investigated only Interferon-gamma for Th1 pathway, and IL-5 and 
IL-13 for Th2 pathway, considering shortage of sputum samples and very 
low detection rates, as in IL-4 mesurement. However, there are several 
cytokines crucial for investions of mechanisms for asthma, such as IL-2, 
IL-4 (especially involved in IgE class switch), IL-10, IL-17, IL-22, and etc. 
 Recently, Ghebre, et al. performed factor and cluster analyses on 18 
sputum cytokines including the above mentioned, with severe asthma and 
moderate-to-severe chronic obstructive pulmonary disease (COPD) 
patients.95 They suggested that sputum cytokine profiling could determine 
distinct and overlapping groups of asthmatics and COPD patients, 
supporting both the British and Dutch hypotheses.95 Bafadhel, et al. had 
also studied profiling of sputum inflammatory mediators in asthma and 
COPD, and reported that recovery of sputum mediators sensitive to 
dithiothreitol (DTT) could be improved using the sputum processing 
technique, which they described.96 These approach and results can be 
applied to future researches related to this study. 
 Nevertheless, Rothers, et al. also reported that productions of IL-5, and 
IL-13, Interferon-gamma, measured in this study, and IL-4 were also 
associated with total IgE levels in active asthma through age 5 years, 
although relations varied temporally.97 Furthermore, Crestani, et al. 
showed that mitogen-stimulated IL-5 production was associated with in 
vivo total IgE levels, independent of other cytokines and circulating 
eosinophils.98
 Our research suggests that respiratory viral proteins including crude RSV 
whole antigens, and its recombinant component protein fragments 
including G protein core fragments, can be possible candidates for 
specific IgE measurements by conventional immunoassay system using 
non-invasive sputum inductions from asthmatics with acute exacerbation. 
Such approach can be used for various clinical applications, including 
mechanism investigation (possible allergenicity of viral proteins, etc.), 
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prediction, diagnosis, treatment and vaccine development99 for respiratory 
virus associated with asthma exacerbation in near future. 
 For example, this approach may be used as a diagnostic tool for 
identifying RSV infection related asthma exacerbations, based upon 
clinical validation by further investigations, like the other recent 
diagnostic approaches.100 Furthermore, there are various specific IgE 
measuring systems, which clinically available and standardized for such 
applications.41,101 This approach might be used for the pretests for 
determinating the indication of anti-IgE therapy, which has been used for 
severe asthma cases. Considering the high cost of the anti-IgE drug 
(omalizumab), our study can provide clinical clues for future researches 
to identify biomarkers predicting responses to anti-IgE therapy.102,103
 Further large scaled and more detailed clinical investigations will be 
helpful for development and expansion of diagnosis and treatment tools 
for respiratory virus related asthma exacerbations. 
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V. CONCLUSION
 In this study, RSV was the most frequently detected viral species 
among the sputa from the exacerbated adult asthmatics. We applied the 
conventional CAP immunoassay to detecting the specific IgE antibodies 
to crude RSV whole antigens and its Gcf, using the sputum samples. 
Gcf-sIgE and IL-5 elevation in the sputa from the adult asthmatics with 
ever detections of RSV by mPCR, suggests that RSV protein sensitization 
and Th2 pathway might have roles on RSV associated asthma 
exacerbations in adults.
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<ABSTRACT(IN KOREAN)>
성인 천식악화와 객담내 호흡기세포융합바이러스
특이 IgE 검출
<지도교수 박 중 원>
연세대학교 대학원 의학과
이 용 원
연구배경: 천식환자의 급성악화가 호흡기 바이러스 감염과 밀접하게
연관되어 있다고 믿어지고 있다. 바이러스 항원에 대한 감작 가능성을
고려하여, 몇몇 연구에서 마우스모델과 천식환자를 대상으로 호흡기합
포체바이러스 (respiratory syn- cytial virus: RSV))에 대한 특이 면역
글로불린 E (IgE)를 검출하고자 시도했다. 그러나 그러한 접근방법이
아직까지 완전히 확립되어 있지 않다.
연구재료 및 방법: 2년 동안, 호흡기 증상의 급성악화를 보인 한국 성
인 천식환자군(60명)과 대조군(10명)의 하기도로부터 총 132개의 유도
객담 검체를 수집하여 호흡기 바이러스 검출률, 종류, 계절적 변화 및
순차적 역동성을 연구하였다. 이들 검체를 가지고 12종의 호흡기 바이
러스(adenovirus, rhino A virus, coronavirus OC43 및 229E/NL63,
metapneumovirus, influenza A and B virus, parainfluenza viruses 1,
2, 3, 그리고 RSV A 및 B)에 대해 다중역전사중합효소연쇄반응
(multiplex RT-PCR: mPCR)을 이용한 검출시험을 수행하였다. 그리고
50개의 객담검체를 선택하여 이들을 대상으로, RSV 조항원 및 RSV
G단백질의 재조합 핵심조각(Gcf)에 대한 특이 IgE를 (유도객담 상층액
내에서) ImmunoCAP 시스템으로 검출하였고, ELISA를 이용하여 인터
페론 감마, IL-5, 및 IL-13도 측정하였다.
- 48 -
연구결과: 132개의 유도객담 검체에 대한 mPCR 검사 결과 총 15건의
호흡기 바이러스 검출이 천식환자군 및 COPD 대조군(각각, 13 및 2건)
에서 관찰되었다. 이들 중 RSV가 가장 빈번하게 검출된 종류였다
(53%, 8/15). 천식환자 3명에서 다종검출 1건, 순차적 검출 2건이 관찰
되었다. 천식환자군에서, 객담 상층액내 재조합 G 단백질 조각에 대한
CAP 특이 IgE (Gcf-sIgE)와 IL-5 수준은 mPCR에서 RSV가 검출된
적이 있는 군에서 더 높았다(각각, p<0.05). RSV-sIgE, Interferon-γ 
및 IL13은 몇몇 연구대상자에서 검출되었으나 연구대상군 사이의 유의
한 차이가 나타나지 않았다. CAP 특이 IgE를 측정한 천식환자군을 대
상으로 ROC 분석을 시행한 결과, mPCR에서 RSV 검출을 예측하기
위한 Gcf-sIgE의 최적 좌표 기준치(the best coordinate cutoff)는
0.285 kU/L 였다(AUC 0.73, 95% CI 0.47-0.82; SE 81.3%, SP 65.4%,
PPV 59.1%, NPV 85.0%).
결론: 이 연구에서, RSV는 성인 천식악화 환자의 객담검체에서 가장
높은 빈도로 검출된 바이러스 종류였다. 본 연구를 통해 통상적으로
사용되는 CAP 면역분석을 적용하여, RSV의 조항원 및 Gcf에 대한 특
이 IgE 항체를 객담검체에서 검출하였다. mPCR 검사에서 RSV가 탐
지된 적이 있는 성인 천식악화 환자군의 객담에서 Gcf 특이 IgE 및
IL-5 가 더 높게 측정된 것은, RSV 단백질에 대한 감작과 Th2 경로
가 RSV와 관련된 성인 천식악화에 대해 역할을 가지고 있을 가능성
을 시사한다.
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면역글로불린 E (IgE)
